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ABSTRACT 
Objective: Exploring the pathophysiological changes in transient receptor potential vanilloid 1 
(TRPV1) receptor of the trigeminovascular system in high-fat, high-sucrose (HFHS) diet-induced 
obesity of experimental animals. 
Background: Clinical and experimental observations suggest a link between obesity and migraine.  
Accumulating evidence indicates that metabolic and immunological alterations associated with 
obesity may potentially modulate trigeminovascular functions. A possible target for obesity-
induced pathophysiological changes is the TRPV1/capsaicin receptor which is implicated in the 
pathomechanism of headaches in a complex way.  
Methods: Male Sprague-Dawley rats were fed a regular (n = 25) or HFHS diet (n = 26) for 20 weeks. 
At the end of the dietary period, body weight of the animals was normally distributed in both 
groups and it was significantly higher in animals on HFHS diet. Therefore, experimental groups were 
regarded as control and HFHS diet-induced obese groups. Capsaicin-induced changes in meningeal 
blood flow and release of calcitonin gene-related peptide (CGRP) from dural trigeminal afferents 
were measured in control and obese rats. The distribution of TRPV1- and CGRP-immunoreactive 
meningeal sensory nerves was also compared in whole mount preparations of the dura mater. 
Metabolic parameters of the animals were assessed by examining glucose and insulin homeostasis 
as well as plasma cytokine concentrations.  
Results: HFHS diet was accompanied by reduced food consumption and greater fluid and energy 
intakes in addition to increased body weight of the animals. HFHS diet increased fasting blood 
glucose and insulin concentrations as well as levels of circulating proinflammatory cytokines 
interleukin-1β and interleukin-6. In obese animals, dural application of the archetypal TRPV1 
agonist capsaicin resulted in significantly augmented vasodilatory and vasoconstrictor responses as 
compared to controls. Diet-induced obesity was also associated with enhanced basal and capsaicin-
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induced CGRP release from meningeal afferents ex vivo. Except for minor morphological changes, 
the distribution of dural TRPV1- and CGRP-immunoreactive afferents was similar in control and 
obese animals. 
Conclusions: Our results suggest that obesity induced by long-term HFHS diet results in 
sensitization of the trigeminovascular system. Changes in TRPV1-mediated vascular reactions and 
CGRP release are pathophysiological alterations that may be of relevance to the enhanced 
headache susceptibility of obese individuals. 
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INTRODUCTION 
Migraine is a common and disabling neurological disorder that seems to be potentiated by obesity. 
Obese persons have increased risk of developing migraine and may suffer from more frequent and 
severe headache attacks 1. Clinical and experimental observations suggest multiple links between 
the pathophysiology of obesity and the primary headache migraine 2, among which the role of 
calcitonin gene-related peptide (CGRP) released from trigeminal afferents might be of particular 
relevance 3. 
CGRP is regarded as one of the key mediators in both nociceptive transmission and meningeal 
arterial vasodilatation that are critical pathophysiological components of headaches 4–6. Current 
migraine therapies are based on reducing CGRP effects by either inhibiting its release from 
meningeal nociceptors (triptans acting on 5-HT1B/1D receptors) or blocking the CGRP receptor (non-
peptide CGRP receptor antagonists “gepants”) 7. Administration of humanized monoclonal 
antibodies targeting CGRP or its receptor appears also a promising new strategy in the therapy of 
migraine 8,9. However, available anti-migraine drugs are not without limitations. Triptans are 
ineffective in a significant percentage of migraine sufferers, their frequent use may lead to 
medication overuse headache and they are contraindicated in patients with risk factors for 
cardiovascular disease that are often associated with obesity 10,11. Furthermore, the development 
of gepants has been interrupted due to side effects. Thus, migraine remains a condition calling for 
additional therapeutic approaches 12. 
Chemosensitive primary afferent neurons which express the transient receptor potential (TRP) 
vanilloid 1 (TRPV1) receptor and may also co-express other members of the TRP receptor family 
represent a unique population of trigeminal ganglion neurons 13–17. They play a fundamental role in 
nociception and their peptidergic population releasing CGRP and/or substance P mediates 
neurogenic vascular reactions in the meninges 13,18–20. Chemosensitive nociceptors represent a 
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promising target for novel migraine therapeutics 21,22. TRPV1 is a molecular integrator of various 
nociceptive stimuli. It can be activated by low pH, noxious heat and different endogenous and 
exogenous agents, such as endovanilloids (e.g. anandamide) and capsaicin, or alcohol, a well-known 
headache trigger 19,23,24. Factors related to tissue damage or inflammation may sensitize the 
receptor by increasing the probability of channel opening upon stimulation 25,26. Enhanced activity 
of the trigeminovascular nociceptive pathway may result from sensitization of TRPV1 receptors 27. 
Prolonged activation of trigeminal afferents may also increase the excitability of second order 
neurons in the caudal trigeminal nucleus 28. Processes of peripheral and central sensitization are 
considered as significant pathophysiological mechanisms of primary headaches. Earlier findings 
from our laboratory have also proved a capsaicin-induced vasoconstrictor response in dural blood 
vessels that was present even after functional degradation of trigeminal chemosensitive afferents 
18. Expression of TRPV1 receptors in a wide variety of non-neuronal tissues including smooth muscle 
cells in different vascular beds may explain the vasoconstrictor effect of capsaicin 29. 
Modification of neuronal and vascular TRPV1 receptor function resulting in altered activity of the 
trigeminovascular system may represent a link between obesity and migraine pathophysiology. 
Chronic expansion of adipose tissue producing bioactive molecules with immunoregulatory 
functions, oxidative and nitrosative stress and microvascular dysfunction are pathophysiological 
correlates of obesity 30 that may modulate trigeminovascular functions as well 31,32. These 
interrelated disturbances may influence TRPV1 channel function leading to enhanced sensitivity of 
the trigeminal nociceptive pathway. Recent experimental studies demonstrated an increased 
capsaicin-induced activity of the trigeminal pain pathway in obese mice 33,34. 
The present experiments were initiated to examine the effects of high-fat, high-sucrose (HFHS) 
diet-induced obesity on the function of trigeminovascular nociceptive afferents in the rat. 
Therefore, TRPV1-dependent meningeal nociceptor function was evaluated in control and obese 
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rats by studying capsaicin-evoked meningeal vascular responses, the ex vivo release of CGRP from 
dural afferents and the immunohistochemical demonstration of TRPV1- and CGRP-immunoreactive 
nerves of the dura mater. The plasma levels of proinflammatory cytokines as well as glucose and 
insulin homeostasis were also determined in control and obese animals to gain further insight into 
possible mechanisms of obesity-related trigeminal neurovascular alterations. 
 
METHODS 
Animals and diet 
Experiments were approved by the Ethical Committee for Animal Care of the University of Szeged 
and the University of Debrecen. Study procedures were carried out in accordance with the Directive 
2010/63/EU of the European Parliament. All efforts were made to minimize the number of animals 
used and their suffering. 
Male Sprague Dawley rats (6 weeks old, weighing 150-170 g, Charles River Laboratories, Hungary) 
were housed in an environmentally controlled room (12-hour light/dark cycle, 22 ± 2 °C, 50-70 % 
relative humidity) and fed according to our recently published protocol 35. Animals in the control 
group (n = 25) received a regular diet containing standard rodent chow (3.20 kcal/g, 59 % 
carbohydrate, 32 % protein, 9 % fat; diet code: S8106-S011 SM R/M-Z+H, ssniff Spezialdiäten 
GmbH, Germany) and tap water. Another group of animals was placed on a HFHS diet (n = 26) 
consisting of high-fat chow (4.56 kcal/g, 35 % carbohydrate, 20 % protein, 45 % fat; diet code: 
824018, Special Diets Services, UK) and 5 % sucrose solution made with tap water. Body weight, 
food and fluid intake of the animals were measured regularly and daily calorie intake was 
calculated. Diets were provided ad libitum for 20 weeks. All experiments were carried out after the 
completion of the dietary treatment period in 26 weeks old animals.  
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Analysis of fasting blood glucose, plasma insulin, interleukin-1β (IL-1β) and interleukin-6 (IL-6) 
concentrations 
Following an overnight fast, rats were anesthetized with intraperitoneally (i.p.) administered 
thiopental sodium (100 mg/kg, Sandoz, Austria). The carotid artery was cannulated for blood 
sampling. After a short stabilization period, blood glucose was determined with a glucometer (Accu-
Chek, Roche Diagnostics, Hungary, detection range: 0.6 - 33.3 mmol/l) and additional samples were 
taken to Eppendorf cups. Blood samples were centrifuged for 2 minutes at 10,000 g and 4 °C. The 
plasma was aliquoted, frozen and stored at -70 °C for later analysis. Plasma concentration of insulin 
was measured by immunoradiometric assay (IRMA) using an insulin IRMA kit (Institute of Isotopes, 
Hungary, detection range: 8.6 - 861 µU/ml, sensitivity: 2.8 µU/ml). IL-1β (Thermo Scientific, USA, 
detection range: 25.6 - 2500 pg/ml, sensitivity: 12 pg/ml) and IL-6 (Life Technologies, USA, 
detection range: 23.5 - 1500 pg/ml, sensitivity: 5 pg/ml) levels were assessed by enzyme-linked 
immunoassay (EIA) specific for rat according to the manufacturer’s instructions. 
 
In vivo recordings of meningeal blood flow 
Changes in meningeal blood flow were measured in an open cranial window preparation 18,36. 
Control and obese rats were anesthetized with thiopental sodium (100 mg/kg, i.p.). The femoral 
artery was cannulated on one side for the measurement of systemic blood pressure.  The body 
temperature of the animals was recorded with a thermoprobe inserted into the rectum and was 
kept at 37–37.5°C with a feedback-controlled heating pad. The trachea was cannulated to allow 
spontaneous breathing throughout the experiment. The head of the animal was fixed in a 
stereotaxic frame and the skin overlying the skull was opened. A cranial window was drilled into the 
parietal bone to expose the dura mater. Blood flow was recorded with a needle-type probe of a 
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laser Doppler flowmeter (Perimed, Sweden) positioned over a branch of the middle meningeal 
artery lying distant from visible cortical blood vessels.  
The exposed dura mater in the cranial window was covered with 40 μl of synthetic interstitial fluid 
(SIF) containing (in mM): 135 NaCl, 5 KCl, 1 MgCl2, 5 CaCl2, 10 glucose and 10 Hepes, pH 7.4. 
Stimulation of the dura mater was performed by topical application of capsaicin (100 nM and 10 
µM, Sigma-Aldrich, Germany), CGRP or histamine (both at 100 µM, Sigma-Aldrich, Germany) at a 
volume of 40 μl. Solutions were removed after 5 min and the dura mater was washed repeatedly 
with SIF to allow the blood flow to return to the basal level. Blood flow was measured in perfusion 
units (PU). Data on meningeal blood flow and systemic blood pressure were processed with the 
Perisoft program (Perimed, Sweden). Basal blood flow was determined as the mean flow during a 
three minute period prior to the stimulation of the dura mater. Percentage changes in meningeal 
blood flow in response to capsaicin, CGRP and histamine were determined as mean flow values 
within the 5 min application period calculated separately at one-minute intervals relative to the 
basal flow.  A stock solution of capsaicin (32 mM) was prepared with the aid of 6% ethanol and 8% 
Tween 80 in saline and was further diluted with SIF. All the other drugs were dissolved in SIF 
immediately before use.  
 
Measurement of CGRP release in ex vivo dura mater preparation 
An ex vivo rat dura mater preparation was used to measure basal and stimulated CGRP release 
from meningeal afferents 37. Control and obese rats were decapitated following deep anesthesia 
with thiopental sodium (150 mg/kg i.p.). After removing the skin and the muscles, the skull was 
divided into halves along the midline. The cerebral hemispheres were removed, skull halves were 
washed at room temperature for 30 min in SIF, then placed in a humid chamber and the cranial 
fossae were filled with 300 μl SIF. Samples of the superfusate were collected with a micropipette at 
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periods of 5 min for CGRP measurement. A control sample was taken in order to determine basal 
CGRP release. Then the dura mater was stimulated with capsaicin at concentrations of 10 and 100 
nM. 100 μl of samples diluted with 25 μl EIA buffer were placed into Eppendorf cups and 
immediately frozen at -70 °C for subsequent analysis. EIA method was used for CGRP determination 
(SPI-Bio, Bertin Pharma, France). The CGRP concentrations of the superfusates were expressed in 
pg/ml. Changes induced in CGRP release by capsaicin were expressed as percentage changes 
relative to the basal release. 
 
Immunohistochemistry 
The distribution of TRPV1- and CGRP-immunoreactive nerve fibers was studied in dural whole 
mount preparations of rats not used in in vivo blood flow recordings or in ex vivo CGRP release 
experiments previously. Control and obese animals were anesthetized deeply with thiopental 
sodium (150 mg/kg, i.p.) and perfused transcardially with physiological saline followed by 4% 
paraformaldehyde in phosphate buffer (pH 7.4). The skin and muscles of the skull were removed 
and the skull was divided into halves along the sagittal suture. After removing the brain, samples of 
the dura mater containing branches of the middle meningeal artery were cut out, postfixed for 2 h 
in the same fixative and processed for staining with the indirect immunofluorescence technique 
using a rabbit polyclonal antiserum raised against the TRPV1 receptor (1:500, Alomone 
Laboratories, Israel) in combination with a monoclonal mouse anti-CGRP antibody (1:500, Sigma-
Aldrich, Germany). IgGs labeled with Cy3 and DL488 were used as secondary antibodies (both 
1:500, Jackson Immunoresearch Laboratories, USA). Whole mount preparations of the dura mater 
were examined under a confocal fluorescence microscope (ZEISS LSM 700, Germany). 
 
Statistics 
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All values were expressed as means ± SEM. Statistical analysis of the data was performed using 
Statistica 12 (StatSoft, USA). In both dietary groups, normality in terminal body weight was proved 
by the Shapiro-Wilk test. For the statistical comparisons of CGRP and cytokine concentrations, 
meningeal blood flow changes, food and fluid intake of the animals the Student’s t-test was used 
for group sizes of n ≥ 10 and the Mann-Whitney U-test for independent measurements of group 
sizes n < 10. One-way ANOVA followed by the Bonferroni test was used to compare metabolic 
parameters of the animals. A probability level of p < 0.05 was regarded as statistically significant. 
 
RESULTS 
Characterization of the diet-induced obesity model 
On average, the HFHS group of animals consumed smaller quantities of food (p < 0.001) and greater 
amount of fluid (p < 0.001) than animals fed with a regular diet. The mean daily caloric intake of 
HFHS rats significantly exceeded the control group (p < 0.001), resulting in a significantly higher 
body weight at the end of the dietary period (616,5 ± 11 g in control and 740.5 ± 15 g in obese 
animals, p < 0.001, n = 17 for both groups, Fig. 1). Diet-induced obesity led to elevations in fasting 
blood glucose (5.75 ± 0.13 vs. 6.54 ± 0.33 mmol/l, p = 0.049, n = 8 and 9) and plasma insulin 
concentrations (17.46 ± 3.31 vs. 48.51 ± 8.67 μU/ml, p = 0.006, n = 8 and 9) in addition to circulating 
levels of the proinflammatory cytokines IL-1β (59.04 ± 2.99 vs. 170.04 ± 23.78 pg/ml, p < 0.001, n = 
8 and 9) and IL-6 (56,39 ± 2,15 vs. 114,46 ± 11,32 pg/ml, p < 0.001, n = 8 and 9) as indicated recently 
35 (Fig. 2). Concentration of all blood markers were above the lower limit of detection. Since body 
weights indicating the obesity status of the animals were different and normally distributed, we 
regarded the dietary groups accordingly as control and HFHS diet-induced obese groups. 
  
Diet-induced obesity potentiates increases in meningeal blood flow elicited by TRPV1 activation  
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The basal blood flow values were in the same range in control and obese rats amounting to 245.2 ± 
18.1 and 244.1 ± 19.6 PU (p = 0.96), respectively. In control rats topical administration of capsaicin 
at 100 nM concentration induced a moderate increase in meningeal blood flow reaching 
significance in the last two minutes of the 5 min application period (p = 0.048 and 0.035, 
respectively, n = 8). Blood flow increasing effect of the same capsaicin concentration was more 
robust in obese animals throughout the whole application period, it reached 20 ± 3.1 % increase in 
the last minute (p ≤ 0.023, n = 9). This increase significantly exceeded the effect measured in 
control rats (p ≤ 0.049, Fig. 3 A, B). Administration of capsaicin at 10 µM reduced meningeal blood 
flow in both groups of animals. In control animals, decrease in meningeal blood flow varied in the 
range from 4.7 ± 2.7 % to 2.7 ± 2.5 % (p ≤ 0.33, n = 6), while this range was 14.5 ±2.9 to 8 ± 2.8 % (p 
≤ 0.036, n = 6) in obese rats. Blood flow reducing effect of 10 µM capsaicin was significantly 
stronger in obese animals from the 2nd to the 4th min compared to controls (p ≤ 0.037, Fig. 3 A, C). 
Histamine and CGRP acting directly on endothelial- or smooth muscle cells of blood vessels induced 
significant increases in meningeal blood flow in both control (p ≤ 0.015, n = 8 both) and obese (p ≤ 
0.035, n = 8 and 10, respectively) rats. No difference regarding the vasodilatation induced by 
histamine (p ≤ 0.98) and CGRP (p ≤ 0.92) administrations could be observed between control and 
HFHS diet-induced obese animals (Fig. 3 D, E).  
Systemic blood pressure of animals was in the same range as we have published recently 35. It was 
138 ± 12 and 142 ± 18 mmHg in control and obese rats, respectively. Drugs administered topically 
to the dura mater failed to influence systemic blood pressure. 
 
Diet-induced obesity enhances basal and TRPV1-mediated CGRP release 
In the ex vivo dura mater preparation of obese animals we measured a significantly increased basal 
CGRP release.  Unstimulated CGRP concentration was 16 ± 1.5 in control and 42.1 ± 6.6 pg/ml in 
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obese rats (p = 0.005). Stimulation with capsaicin significantly enhanced the release of CGRP from 
meningeal afferents in skull preparations obtained from both control and obese animals. Capsaicin 
at a concentration of 10 nM elevated CGRP release to 34.7 ± 2.3 pg/ml (196.6 ± 21.2 % of basal 
release, p < 0.001, n = 7) and at 100 nM concentration to 75.6 ± 7 pg/ml (612.7 ± 58.9 % of basal 
release, p < 0.001, n = 6) in rats maintained on a regular diet. In obese animals capsaicin at 10 nM 
concentration increased the release of CGRP to 120 ± 27.6 pg/ml (300.1 ± 60.1 % of basal release, p 
= 0.004, n = 11) and at 100 nM to 358.1 ± 95.5 pg/ml (853.1 ± 76 % of basal release, p = 0.004, n = 
11). HFHS diet-induced obesity resulted in a significantly greater CGRP release in response to both 
capsaicin concentrations as compared with the control (p = 0.027 and p < 0.048, respectively, Fig. 
4). 
 
Effect of HFHS diet on TRPV1- and CGRP-immunoreactive nerve fibers of the dura mater 
In the dura mater of control animals TRPV1- and CGRP-immunoreactive nerve fibres were 
distributed over the whole supratentorial dura mater. Many TRPV1-immunoreactive nerves were 
seen running in small nerve bundles in association with dural blood vessels. Single axons were also 
observed in avascular regions of the meningeal tissue, i.e. in areas at a distance from larger blood 
vessels, where they formed loose nerve plexuses. CGRP was colocalized with TRPV1 in most of 
these nerve fibres. Although in whole mount dura preparations of obese rats, distribution of 
TRPV1- and CGRP-immunoreactive afferents was similar to that seen in control dura mater 
preparations, many single axons showed characteristic changes. While CGRP-immunoreactivity was 
distributed evenly in the afferents of control dura, in whole mounts of obese animals the 
immunoreactivity was observed in the form of a string of pearls (Fig. 5). 
 
DISCUSSION 
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The present study was undertaken to study the effect of a state of obesity on trigeminovascular 
TRPV1 receptor function, a pivotal component of headache mechanisms. Therefore, rats were fed 
on a HFHS western-type diet to create a metabolic and immunological condition that may also 
characterize obese headache sufferers. 
HFHS diet altered the eating behavior of animals indicating that dietary treatment influenced 
processes involved in the regulation of food intake and energy balance 38. The lower food 
consumption and higher fluid and calorie intakes in HFHS-fed animals are in agreement with 
previous reports in which the energy density and palatability of the diet were manipulated in a 
similar way 39–41. The accumulation of adipose tissue was accompanied by impairments in glucose 
and insulin homeostasis and a low-grade systemic inflammatory milieu. The present findings 
demonstrate that our animal model of diet-induced obesity possessed many of the metabolic 
alterations that have been previously suggested to be associated with obesity as well as with the 
pathophysiology of migraine 42–44. 
The function of trigeminal nociceptors can be assessed by studying vascular responses in relation to 
neuropeptide release from dural afferents. Previous studies have confirmed that the meningeal 
vasodilatory action of capsaicin is mediated by the activation of TRPV1 receptors in chemosensitive 
afferents and the consequent release of CGRP from their peripheral endings 18. Changes in 
metabolic conditions may modify the functionality of trigeminal chemosensitive neurons. 
Meningeal TRPV1 expressing nerves in streptozotocin-induced diabetic rats were found impaired 
showing reduced neurogenic sensory vasodilatation, decreased capsaicin-evoked CGRP release and 
reduction in the number of TRPV1-immunoreactive nerve fibers of the dura mater 45. The present 
study provides the first direct evidence that diet-induced obesity in rats leads to augmented 
vasodilatory responses in meningeal blood vessels following activation of trigeminal TRPV1 
receptors. Enhanced vascular reactions were selective for capsaicin since neither CGRP- nor 
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histamine-induced vascular reactions in diet-induced obese animals differed from the control. 
Measurement of capsaicin-induced CGRP release in ex vivo dura mater preparations of the obese 
rats indicates that an increased CGRP release from meningeal nociceptive afferent nerves may 
account for the enhanced capsaicin-induced vasodilatation. The current results are in accordance 
with recent studies in our laboratory that furnished evidence for an enhanced CGRP-mediated 
neurogenic sensory vasodilatation in the meninges of obese animals upon the activation of 
transient receptor potential ankyrin 1 (TRPA1) channels by the environmental irritant acrolein 35. 
However, TRPA1 receptors are expressed only in a subset of TRPV1-positive chemosensitive 
primary afferent nerves 46. 
Although most studies dealing with headache mechanisms focus on trigeminal peptidergic 
afferents, it should be emphasized that a large population of TRPV1 expressing neurons does not 
contain neuropeptides 47. Non-peptidergic nociceptive primary sensory neurons can be identified 
through their binding of the plant lectin, Griffonia simplicifolia isolectin B4 (IB4). The possible role 
of non-peptidergic nociceptive afferents in the pathomechanism of headaches remains to be 
elucidated. It is conceivable that peptidergic and non-peptidergic TRPV1-expressing neurons 
provide parallel afferent pathways for the transmission of nociceptive signals 21. Activation of 
peptidergic neurons induces increases in meningeal blood flow but release of CGRP from their 
central terminals in the trigeminal nucleus has presumably only a presynaptic modulatory effect 
controlling the neurotransmitter release in other populations of primary afferents 48. Non-
peptidergic TRPV1 expressing trigeminal neurons fail to contribute to local neurogenic vascular 
reactions in the dura mater, but they may provide a direct transmission of nociceptive signals to 
second order neurons of the pain pathway 21. Obesity-related factors that alter the function of 
TRPV1 receptors in CGRP-containing meningeal afferents may also have the potential to affect 
TRPV1 in non-peptidergic trigeminal sensory neurons. 
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Earlier observations in our laboratory demonstrated a capsaicin-induced vasoconstriction in 
meningeal blood vessels that appeared parallel with the CGRP-induced vasodilatation and was 
independent of neural processes 18. The mechanism of capsaicin-induced vasoconstriction is not 
completely clarified. It is generally regarded as a direct vascular action of capsaicin 49–51, but 
contribution of TRPV1 receptors expressed in vascular smooth muscle cells cannot be excluded 29. 
Our present findings indicated that in dural arteries both the vasodilatory and the vasoconstrictor 
actions of capsaicin were enhanced in obese animals.  
The mechanisms responsible for obesity-associated changes in capsaicin-evoked meningeal 
vascular responses and CGRP release are likely to involve complex dose- and time-dependent 
interactions among multiple causative factors, which may appear already at an early stage of the 
dietary period enabling them to act chronically on the trigeminovascular system. High-fat diet has 
been shown to increase calcium influx in both cultured trigeminal ganglion neurons and vascular 
smooth muscle cells of cerebral arteries 34,52, therefore alterations in calcium homeostasis in 
trigeminal primary afferents and meningeal vasculature could potentially contribute to altered 
neurocrine and vasoconstrictor responses under basal conditions and to stimulation with capsaicin 
in obese animals. 
The increased basal and capsaicin-induced CGRP release that was measured in the ex vivo dura 
mater preparation of HFHS diet-induced obese animals may result from a sensitization of the TRPV1 
receptor. Sensitization may occur in several ways such as modifications in gating properties of the 
ion channel, increased trafficking of the receptor to cell membrane or increased production of the 
TRPV1 protein 22. In the dura mater whole mount preparations of lean and obese animals, in accord 
with previous data 45,53, the density and distribution of TRPV1- and CGRP-immunoreactive nerve 
fibers were similar. It is noteworthy that microscopic examination revealed characteristic structural 
changes in dural afferents of diet-induced obese animals. The pearl-like appearance of CGRP-
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immunoreactivity might be the morphological correlate of enhanced CGRP release 54,55. Despite the 
known limitations of immunohistochemistry to detect subtle changes in receptor protein content, 
our findings indicate that obesity-associated potentiation of capsaicin-induced neurogenic sensory 
vasodilatation was brought about in the absence of obvious changes in TRPV1-immunoreactivity of 
dural afferents. Sensitization of the TRPV1 receptor is more likely the consequence of the release of 
proinflammatory agents produced in the adipose tissue 56, which may also influence neuropeptide-
mediated vascular reactions. Indeed, we measured increased plasma concentrations of the 
proinflammatory cytokines IL-1β and IL-6 in obese animals. IL-1β may directly modify the gating 
properties of TRPV1 to noxious stimuli in primary sensory neurons while leaving the recruitment of 
the channel to plasma membrane unaffected 57. Additionally, IL-1β has been shown to enhance 
basal and capsaicin-induced CGRP release in the rat trigeminal ganglion neurons 58,59, whereas the 
intraplantar injection of this cytokine augmented the capsaicin-induced neurogenic sensory 
vasodilatation without altering the vascular action of CGRP 60. In the trigeminal ganglion, IL-1β has 
also been demonstrated to increase the production of prostaglandin E2 
59, which may lower the 
heat activation threshold of TRPV1 and increase capsaicin-evoked responses in sensory neurons 61–
63 as well as the release of CGRP in slices of the trigeminal nucleus caudalis 64. IL-6 in conjunction 
with its soluble receptor (sIL-6R) may have abilities to reduce heat threshold and increase heat-
activated inward currents in rat dorsal root ganglion cells with a possible involvement of TRPV1 65. 
Both IL-1β and IL-6/sIL-6R complex have been found to potentiate heat-stimulated CGRP release 
from an in vitro rat skin preparation 66. The obesity-related enhancement in systemic and cerebral 
oxidative stress along with the marked hyperinsulinemia might also contribute to changes in 
TRPV1-mediated trigeminovascular responses 67,68. A major role of the proinflammatory cytokine 
tumor necrosis factor α (TNFα) is not very likely since its serum level was not affected in our diet-
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induced obesity model 35. This, however, does not exclude the involvement of local TNFα 
production in meningeal TRPV1 sensitization 69. 
The particular combination of high-fat chow and sucrose solution applied in this study seems to be 
a reliable method to correspond certain criteria of both experimental and human obesity. However, 
it remains unclear whether the present findings are specific to dietary factors or whether they can 
be attributed to the obese state itself regardless of the etiology. This uncertainty associated with 
animal models of diet-induced obesity should be taken into consideration when interpreting the 
data. 
Sex-related differences affecting the distribution and metabolic function of adipose tissue may 
modify the effect of diet-induced obesity on nociceptor function in females 70.  Additionally, the 
female sex hormone estradiol may modify nociceptor function by acting directly on the TRPV1 ion 
channel or by increasing its expression in dorsal root ganglion neurons 71. Since, the present study 
was undertaken exclusively in male rats, extrapolation of the findings to females requires some 
caution. 
Obesity and TRPV1 receptor function may have a versatile connection. Recent experimental results 
attributed a potential therapeutic effect of TRPV1 receptor stimulation in obesity since capsaicin 
dose-dependently increased intracellular calcium concentration in preadipocytes that inhibited 
their differentiation 72. 
Considering the central role of chemosensitive trigeminal afferents in the pathomechanism of 
headaches, both TRPV1 receptor agonists (desensitizing the channel protein) and antagonists have 
potential in migraine therapy. A novel approach to modulate TRPV1 receptor function may be the 
development of drugs preventing the phosphorylation of the receptor, thereby counteracting the 
increased probability of channel opening. Therefore, kinase inhibitors preventing the sensitization 
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of the receptor may provide a promising strategy for migraine therapy, especially in obese persons, 
where altered TRPV1 receptor function seems to be an important pathophysiological factor 22,73. 
In conclusion, our study demonstrates that obesity induced by long-term HFHS feeding increases 
TRPV1-mediated CGRP release and neurogenic sensory vasodilatation in the dura mater encephali 
of rats. Augmented trigeminovascular responses upon TRPV1 activation occur without obvious 
changes in TRPV1- and CGRP-immunoreactivity of meningeal nociceptors. HFHS diet-induced 
obesity also results in enhanced capsaicin-induced vasoconstriction, which may also be of relevance 
to obesity-headache relationship. The enhanced vasoconstrictor activity of meningeal blood vessels 
may impair the effective removal of pain-producing tissue mediators involved in the induction or 
aggravation of headache attacks or may delay the restoration of tissue homeostasis. 
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FIGURE LEGENDS 
Fig. 1 
Average daily food-, fluid- and calorie intakes of rats maintained on regular or HFHS diet (n = 17 in 
both groups) *: statistically different from the control. 
Fig. 2 
Effect of diet-induced obesity on plasma concentrations of (A) interleukin-1β (IL-1β), interleukin-6 
(IL-6), (B) fasting blood glucose and (C) fasting plasma insulin concentrations. The number of 
experiments is indicated in the bars. *: statistically different from the control. 
Fig. 3 
Effect of TRPV1 receptor activation on meningeal blood flow. (A) Original recordings and (B-E) 
statistical evaluation of blood flow-modifying effects of topical applications of capsaicin (100 nM 
and 10 µM), histamine and CGRP (100 µM both). *: statistically different from the basal flow, #: 
statistically different from the control. 
Fig. 4 
TRPV1 receptor activation-induced release of CGRP from meningeal afferents. CGRP concentrations 
(pg/ml) measured after topical application of SIF and capsaicin (10 and 100 nM). The number of 
experiments is indicated in the bars. *: statistically different from the basal release, #: statistically 
different from the control. 
Fig. 5  
Immunohistochemical photomicrographs showing the distribution of TRPV1- (A, D) and CGRP- (B, C, 
E, F) immunoreactive nerve fibers in the dura mater of control (A - C) and HFHS diet-induced obese 
(D - F) rats. Distribution of TRPV1- and CGRP-immunoreactive afferents is similar in the dura mater 
preparations of control and obese animals. The pearl-like distribution of CGRP-immunoreactivity 
may be the morphological correlate of enhanced CGRP release in obese animals. Scale bar on E 
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represents 50 µm and applies for A, B, D and E, scale bare on F represents 25 µm and applies for C 
and F, MMA: branch of the middle meningeal artery. 
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Average daily food-, fluid- and calorie intakes of rats maintained on regular or HFHS diet (n = 17 in both 
groups) *: statistically different from the control.  
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Effect of diet-induced obesity on plasma concentrations of (A) interleukin-1β (IL-1β), interleukin-6 (IL-6), 
(B) fasting blood glucose and (C) fasting plasma insulin concentrations. The number of experiments is 
indicated in the bars. *: statistically different from the control.  
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Effect of TRPV1 receptor activation on meningeal blood flow. (A) Original recordings and (B-E) statistical 
evaluation of blood flow-modifying effects of topical applications of capsaicin (100 nM and 10 µM), histamine 
and CGRP (100 µM both). *: statistically different from the basal flow, #: statistically different from the 
control.  
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TRPV1 receptor activation-induced release of CGRP from meningeal afferents. CGRP concentrations (pg/ml) 
measured after topical application of SIF and capsaicin (10 and 100 nM). The number of experiments is 
indicated in the bars. *: statistically different from the basal release, #: statistically different from the 
control.  
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Immunohistochemical photomicrographs showing the distribution of TRPV1- (A, D) and CGRP- (B, C, E, F) 
immunoreactive nerve fibers in the dura mater of control (A - C) and HFHS diet-induced obese (D - F) rats. 
Distribution of TRPV1- and CGRP-immunoreactive afferents is similar in the dura mater preparations of 
control and obese animals. The pearl-like distribution of CGRP-immunoreactivity may be the morphological 
correlate of enhanced CGRP release in obese animals. Scale bar on E represents 50 µm and applies for A, B, 
D and E, scale bare on F represents 25 µm and applies for C and F, MMA: branch of the middle meningeal 
artery.  
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